Daehan Nupharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	18,940	19,966	29,726	19,202	21,156	15,303
Short-Term Investments	1,000	1,000	820	1,820	1,494	820
Trading Asset Securities	13,444	12,037	6,971	2,758	6,720	6,197
Cash & Short-Term Investments	33,383	33,003	37,517	23,780	29,370	22,319
Cash Growth	-1.82%	-12.03%	57.77%	-19.03%	31.59%	5.38%
Accounts Receivable	32,270	31,333	34,037	35,108	32,950	26,510
Other Receivables	8,813	6,684	4,935	3,552	2,554	3,408
Receivables	42,132	39,067	39,672	39,959	37,104	31,878
Inventory	42,151	41,076	37,215	32,890	30,448	20,391
Prepaid Expenses	78.63	141.05	72.81	82.75	3,643	53.85
Other Current Assets	1,075	606.21	877.53	1,773	2,077	1,391
Total Current Assets	118,820	113,893	115,354	98,485	102,641	76,033
Property, Plant & Equipment	138,052	133,290	85,042	54,313	46,978	46,294
Long-Term Investments	14,096	18,659	17,874	21,420	18,042	20,513
Other Intangible Assets	1,113	1,637	1,122	563.83	336.14	423.59
Long-Term Deferred Tax Assets	2,857	2,946	1,164	1,418	594.43	10,327
Other Long-Term Assets	954.06	759.52	729.93	727.64	767.44	4,052
Total Assets	275,892	271,184	221,285	176,927	169,359	157,643
Accounts Payable	12,425	14,999	12,569	10,230	11,633	8,179
Accrued Expenses	7,532	8,979	8,248	7,496	6,608	5,787
Short-Term Debt	46,690	43,878	39,655	35,672	20,523	15,812
Current Portion of Long-Term Debt	1,500	-	-	-	13,461	4,700
Current Portion of Leases	539.29	586.59	531.14	556.37	426.7	442.09
Current Income Taxes Payable	537.12	418.6	2,232	1,988	-	4,180
Other Current Liabilities	6,580	4,510	8,646	5,815	5,932	5,948
Total Current Liabilities	75,803	73,371	71,881	61,758	58,584	45,049
Long-Term Debt	58,500	54,087	18,831	-	2,006	15,631
Long-Term Leases	321.54	404.74	409.87	369.21	226.1	335.16
Pension & Post-Retirement Benefits	2,472	2,768	4,062	4,761	4,931	4,792
Other Long-Term Liabilities	585.37	605.05	662.14	682.91	653.17	9,371
Total Liabilities	137,682	131,235	95,846	67,571	66,400	75,178
Common Stock	7,177	7,177	7,177	7,177	7,177	7,177
Additional Paid-In Capital	55,676	55,676	55,676	55,676	55,676	55,676
Retained Earnings	69,789	68,194	54,497	41,112	30,609	7,336
Treasury Stock	-3,075	-3,075	-3,075	-3,075	-3,075	-3,075
Comprehensive Income & Other	8,643	11,976	11,163	8,466	12,572	15,351
Shareholders' Equity	138,210	139,949	125,439	109,356	102,959	82,465
Total Liabilities & Equity	275,892	271,184	221,285	176,927	169,359	157,643
Total Debt	107,551	98,956	59,427	36,598	36,642	36,920
Net Cash (Debt)	-74,167	-65,953	-21,910	-12,818	-7,272	-14,601
Net Cash Per Share	-	-4699.10	-1561.08	-913.25	-518.12	-1040.30
Filing Date Shares Outstanding	-	14.04	14.04	14.04	14.04	14.04
Total Common Shares Outstanding	-	14.04	14.04	14.04	14.04	14.04
Working Capital	43,017	40,523	43,473	36,727	44,058	30,984
Book Value Per Share	-	9971.21	8937.39	7791.50	7335.72	5875.57
Tangible Book Value	137,096	138,312	124,317	108,792	102,623	82,042
Tangible Book Value Per Share	-	9854.56	8857.49	7751.32	7311.77	5845.39
Land	13,776	13,776	13,589	13,021	13,021	12,938
Buildings	42,784	42,784	43,391	40,518	32,676	32,734
Machinery	32,654	32,631	31,095	30,107	26,974	25,859
Construction In Progress	84,467	78,808	29,948	1,143	2,366	179.45